1. Clinical pharmacokinetics of the antipurine antifolate (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolic acid (lometrexol) administered with an oral folic acid supplement;Wedge;Clin Cancer Res,1995
2. Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol;Mendelsohn;Invest New Drugs,1996
3. The role of dietary folate in modulation of folate receptor expression, folylpolyglutamate synthetase activity and the efficacy and toxicity of lometrexol;Mendelsohn;Adv Enzyme Regul,1996
4. Augmentation of the therapeutic activity of lometrexol-(6-R)5,10-dideazatetrahydrofolate- by oral folic acid;Alati;Cancer Res,1996
5. Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue;Sessa;Clin Cancer Res,1996